List of Tables
Table 1. Global Autoimmune Disease Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of NSAIDs
Table 3. Key Players of Anti-Inflammatory
Table 4. Key Players of Interferons
Table 5. Key Players of Antihyperglycemics
Table 6. Key Players of Others
Table 7. Global Autoimmune Disease Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Autoimmune Disease Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Autoimmune Disease Drug Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Autoimmune Disease Drug Market Share by Region (2020-2025)
Table 11. Global Autoimmune Disease Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Autoimmune Disease Drug Market Share by Region (2026-2031)
Table 13. Autoimmune Disease Drug Market Trends
Table 14. Autoimmune Disease Drug Market Drivers
Table 15. Autoimmune Disease Drug Market Challenges
Table 16. Autoimmune Disease Drug Market Restraints
Table 17. Global Autoimmune Disease Drug Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Autoimmune Disease Drug Market Share by Players (2020-2025)
Table 19. Global Top Autoimmune Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Drug as of 2024)
Table 20. Ranking of Global Top Autoimmune Disease Drug Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Autoimmune Disease Drug Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Autoimmune Disease Drug, Headquarters and Area Served
Table 23. Global Key Players of Autoimmune Disease Drug, Product and Application
Table 24. Global Key Players of Autoimmune Disease Drug, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Autoimmune Disease Drug Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Autoimmune Disease Drug Revenue Market Share by Type (2020-2025)
Table 28. Global Autoimmune Disease Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Autoimmune Disease Drug Revenue Market Share by Type (2026-2031)
Table 30. Global Autoimmune Disease Drug Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Autoimmune Disease Drug Revenue Market Share by Application (2020-2025)
Table 32. Global Autoimmune Disease Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Autoimmune Disease Drug Revenue Market Share by Application (2026-2031)
Table 34. North America Autoimmune Disease Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Autoimmune Disease Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Autoimmune Disease Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Autoimmune Disease Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Autoimmune Disease Drug Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Autoimmune Disease Drug Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Autoimmune Disease Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Autoimmune Disease Drug Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Autoimmune Disease Drug Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Autoimmune Disease Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Autoimmune Disease Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Autoimmune Disease Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Autoimmune Disease Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Autoimmune Disease Drug Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Autoimmune Disease Drug Market Size by Country (2026-2031) & (US$ Million)
Table 49. Abbott Laboratories Company Details
Table 50. Abbott Laboratories Business Overview
Table 51. Abbott Laboratories Autoimmune Disease Drug Product
Table 52. Abbott Laboratories Revenue in Autoimmune Disease Drug Business (2020-2025) & (US$ Million)
Table 53. Abbott Laboratories Recent Development
Table 54. Pfizer Company Details
Table 55. Pfizer Business Overview
Table 56. Pfizer Autoimmune Disease Drug Product
Table 57. Pfizer Revenue in Autoimmune Disease Drug Business (2020-2025) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. AbbVie Company Details
Table 60. AbbVie Business Overview
Table 61. AbbVie Autoimmune Disease Drug Product
Table 62. AbbVie Revenue in Autoimmune Disease Drug Business (2020-2025) & (US$ Million)
Table 63. AbbVie Recent Development
Table 64. Eli Lilly Company Details
Table 65. Eli Lilly Business Overview
Table 66. Eli Lilly Autoimmune Disease Drug Product
Table 67. Eli Lilly Revenue in Autoimmune Disease Drug Business (2020-2025) & (US$ Million)
Table 68. Eli Lilly Recent Development
Table 69. Bristol-Myers Squibb Company Details
Table 70. Bristol-Myers Squibb Business Overview
Table 71. Bristol-Myers Squibb Autoimmune Disease Drug Product
Table 72. Bristol-Myers Squibb Revenue in Autoimmune Disease Drug Business (2020-2025) & (US$ Million)
Table 73. Bristol-Myers Squibb Recent Development
Table 74. AstraZeneca plc Company Details
Table 75. AstraZeneca plc Business Overview
Table 76. AstraZeneca plc Autoimmune Disease Drug Product
Table 77. AstraZeneca plc Revenue in Autoimmune Disease Drug Business (2020-2025) & (US$ Million)
Table 78. AstraZeneca plc Recent Development
Table 79. GlaxoSmithKline Company Details
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Autoimmune Disease Drug Product
Table 82. GlaxoSmithKline Revenue in Autoimmune Disease Drug Business (2020-2025) & (US$ Million)
Table 83. GlaxoSmithKline Recent Development
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Autoimmune Disease Drug Product
Table 87. Roche Revenue in Autoimmune Disease Drug Business (2020-2025) & (US$ Million)
Table 88. Roche Recent Development
Table 89. Biogen Company Details
Table 90. Biogen Business Overview
Table 91. Biogen Autoimmune Disease Drug Product
Table 92. Biogen Revenue in Autoimmune Disease Drug Business (2020-2025) & (US$ Million)
Table 93. Biogen Recent Development
Table 94. Amgen Company Details
Table 95. Amgen Business Overview
Table 96. Amgen Autoimmune Disease Drug Product
Table 97. Amgen Revenue in Autoimmune Disease Drug Business (2020-2025) & (US$ Million)
Table 98. Amgen Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. Authors List of This Report
List of Figures
Figure 1. Autoimmune Disease Drug Picture
Figure 2. Global Autoimmune Disease Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Autoimmune Disease Drug Market Share by Type: 2024 VS 2031
Figure 4. NSAIDs Features
Figure 5. Anti-Inflammatory Features
Figure 6. Interferons Features
Figure 7. Antihyperglycemics Features
Figure 8. Others Features
Figure 9. Global Autoimmune Disease Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Autoimmune Disease Drug Market Share by Application: 2024 VS 2031
Figure 11. Rheumatoid Arthritis Case Studies
Figure 12. Type 1 Diabetes Case Studies
Figure 13. Multiple Sclerosis Case Studies
Figure 14. Psoriasis Case Studies
Figure 15. Lupus Case Studies
Figure 16. Inflammatory Bowel Disease Case Studies
Figure 17. Others Case Studies
Figure 18. Autoimmune Disease Drug Report Years Considered
Figure 19. Global Autoimmune Disease Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20. Global Autoimmune Disease Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Autoimmune Disease Drug Market Share by Region: 2024 VS 2031
Figure 22. Global Autoimmune Disease Drug Market Share by Players in 2024
Figure 23. Global Top Autoimmune Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Drug as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Autoimmune Disease Drug Revenue in 2024
Figure 25. North America Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. North America Autoimmune Disease Drug Market Share by Country (2020-2031)
Figure 27. United States Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Canada Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe Autoimmune Disease Drug Market Share by Country (2020-2031)
Figure 31. Germany Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. France Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. U.K. Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Italy Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Russia Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Nordic Countries Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Autoimmune Disease Drug Market Share by Region (2020-2031)
Figure 39. China Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Japan Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. India Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Australia Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America Autoimmune Disease Drug Market Share by Country (2020-2031)
Figure 47. Mexico Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Brazil Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Autoimmune Disease Drug Market Share by Country (2020-2031)
Figure 51. Turkey Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. UAE Autoimmune Disease Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Abbott Laboratories Revenue Growth Rate in Autoimmune Disease Drug Business (2020-2025)
Figure 55. Pfizer Revenue Growth Rate in Autoimmune Disease Drug Business (2020-2025)
Figure 56. AbbVie Revenue Growth Rate in Autoimmune Disease Drug Business (2020-2025)
Figure 57. Eli Lilly Revenue Growth Rate in Autoimmune Disease Drug Business (2020-2025)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Disease Drug Business (2020-2025)
Figure 59. AstraZeneca plc Revenue Growth Rate in Autoimmune Disease Drug Business (2020-2025)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Autoimmune Disease Drug Business (2020-2025)
Figure 61. Roche Revenue Growth Rate in Autoimmune Disease Drug Business (2020-2025)
Figure 62. Biogen Revenue Growth Rate in Autoimmune Disease Drug Business (2020-2025)
Figure 63. Amgen Revenue Growth Rate in Autoimmune Disease Drug Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
